155 related articles for article (PubMed ID: 15542244)
1. Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.
Ray M; Bohr I; McIntosh JM; Ballard C; McKeith I; Chalon S; Guilloteau D; Perry R; Perry E; Court JA; Piggott M
Neurosci Lett; 2004 Dec; 372(3):220-5. PubMed ID: 15542244
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.
Bohr IJ; Ray MA; McIntosh JM; Chalon S; Guilloteau D; McKeith IG; Perry RH; Clementi F; Perry EK; Court JA; Piggott MA
Exp Neurol; 2005 Feb; 191(2):292-300. PubMed ID: 15649484
[TBL] [Abstract][Full Text] [Related]
3. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
[TBL] [Abstract][Full Text] [Related]
4. Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
Duda JE
Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():3-14. PubMed ID: 14676464
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
6. Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.
Kulak JM; McIntosh JM; Quik M
Mol Pharmacol; 2002 Jan; 61(1):230-8. PubMed ID: 11752225
[TBL] [Abstract][Full Text] [Related]
7. Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.
McCallum SE; Parameswaran N; Bordia T; McIntosh JM; Grady SR; Quik M
Mol Pharmacol; 2005 Sep; 68(3):737-46. PubMed ID: 15933214
[TBL] [Abstract][Full Text] [Related]
8. Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.
Quik M; Polonskaya Y; Kulak JM; McIntosh JM
J Neurosci; 2001 Aug; 21(15):5494-500. PubMed ID: 11466420
[TBL] [Abstract][Full Text] [Related]
9. 5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypes.
Kulak JM; Sum J; Musachio JL; McIntosh JM; Quik M
J Neurochem; 2002 Apr; 81(2):403-6. PubMed ID: 12064487
[TBL] [Abstract][Full Text] [Related]
10. Intralaminar nuclei of the thalamus in Lewy body diseases.
Brooks D; Halliday GM
Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
[TBL] [Abstract][Full Text] [Related]
11. Alpha-conotoxin analogs with enhanced affinity for nicotinic receptors and acetylcholine-binding proteins.
Tsetlin VI; Kasheverov IE; Zhmak MN; Utkin YN; Vulfius CA; Smit AB; Bertrand D
J Mol Neurosci; 2006; 30(1-2):77-8. PubMed ID: 17192636
[TBL] [Abstract][Full Text] [Related]
12. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
[TBL] [Abstract][Full Text] [Related]
13. Effect of novel alpha-conotoxins on nicotine-stimulated [3H]dopamine release from rat striatal synaptosomes.
Azam L; McIntosh JM
J Pharmacol Exp Ther; 2005 Jan; 312(1):231-7. PubMed ID: 15316087
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
[TBL] [Abstract][Full Text] [Related]
15. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.
Mogg AJ; Whiteaker P; McIntosh JM; Marks M; Collins AC; Wonnacott S
J Pharmacol Exp Ther; 2002 Jul; 302(1):197-204. PubMed ID: 12065717
[TBL] [Abstract][Full Text] [Related]
16. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
McIntosh JM; Azam L; Staheli S; Dowell C; Lindstrom JM; Kuryatov A; Garrett JE; Marks MJ; Whiteaker P
Mol Pharmacol; 2004 Apr; 65(4):944-52. PubMed ID: 15044624
[TBL] [Abstract][Full Text] [Related]
17. Declines in different beta2* nicotinic receptor populations in monkey striatum after nigrostriatal damage.
Kulak JM; Musachio JL; McIntosh JM; Quik M
J Pharmacol Exp Ther; 2002 Nov; 303(2):633-9. PubMed ID: 12388645
[TBL] [Abstract][Full Text] [Related]
18. Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage.
Quik M; Polonskaya Y; McIntosh JM; Kulak JM
Neuroscience; 2002; 112(3):619-30. PubMed ID: 12074903
[TBL] [Abstract][Full Text] [Related]
19. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy.
Schmeichel AM; Buchhalter LC; Low PA; Parisi JE; Boeve BW; Sandroni P; Benarroch EE
Neurology; 2008 Jan; 70(5):368-73. PubMed ID: 18227417
[TBL] [Abstract][Full Text] [Related]
20. Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice.
Quik M; Sum JD; Whiteaker P; McCallum SE; Marks MJ; Musachio J; McIntosh JM; Collins AC; Grady SR
Mol Pharmacol; 2003 May; 63(5):1169-79. PubMed ID: 12695545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]